Evidence map›Paper›PMID 34540163›Full record

ReviewIranian journal of microbiology2021

Molecular epidemiology of hypervirulent

Rahimeh Sanikhani, Mohammad Moeinirad, Fereshteh Shahcheraghi, Arezou Lari, Sepideh Fereshteh, Amin Sepehr, Afsaneh Salimi, Farzad Badmasti

Abstract readReview
In one paragraph

Review in Iranian journal of microbiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. A systematic review of hypervirulentFrontiers in medicine · 2025
    Pooled it
  2. Article
  3. Article
  4. Epidemiological features of hypermucoviscousFrontiers in cellular and infection microbiology · 2026
    Article
  5. Article
  6. Article
  7. Review
  8. Molecular and genetic features of a blaAnnals of clinical microbiology and antimicrobials · 2025
    Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Molecular Profiling of a Multi-Strain HypervirulentInfection and drug resistance · 2023
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Rahimeh SanikhaniDepartment of Bacteriology, Pasteur Institute of Iran, Tehran, Iran.
Mohammad MoeiniradDepartment of Pathobiology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
Fereshteh ShahcheraghiDepartment of Bacteriology, Pasteur Institute of Iran, Tehran, Iran.
Arezou LariDepartment of Systems Biomedicine, Pasteur Institute of Iran, Tehran, Iran.
Sepideh FereshtehDepartment of Bacteriology, Pasteur Institute of Iran, Tehran, Iran.
Amin SepehrDepartment of Bacteriology, Pasteur Institute of Iran, Tehran, Iran.
Afsaneh SalimiDepartment of Bacteriology, Pasteur Institute of Iran, Tehran, Iran.
Farzad BadmastiDepartment of Bacteriology, Pasteur Institute of Iran, Tehran, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Classical (CKp) and hypervirulent (hvKp)

Indexed as

Hypervirulent Klebsiella pneumoniaMolecular typingPathotypesi genotypesVirulence factors

Identifiers

PMID34540163
PMCPMC8416590

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.